Arax Advisory Partners’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
GA
Arax Advisory Partners's TMCI Position: Q3 2026 in Review
Arax Advisory Partners reduced its Treace Medical Concepts (TMCI) stake by 36% in Q3 2026, selling an estimated $38K and leaving 14,949 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3114.
Arax Advisory Partners first reported a position in TMCI in Q4 2024 and has held it in 6 quarters since. The position peaked at $93.3K in Q2 2026. 115 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.
- Arax Advisory Partners held 14,949 shares of Treace Medical Concepts worth $66.4K as of Q3 2026.
- Arax Advisory Partners sold 8,483 Treace Medical Concepts shares in Q3 2026, an estimated $38K.
- Treace Medical Concepts made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #3114 holding.
- Arax Advisory Partners first reported a position in Treace Medical Concepts in Q4 2024 and has held it in 6 quarters since.
- Arax Advisory Partners's Treace Medical Concepts position peaked at $93.3K in Q2 2026.
- 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.